Detalles de la búsqueda
1.
Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band Dosing.
Clin Infect Dis
; 71(12): 3055-3060, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31867594
2.
Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32122887
3.
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture.
Antimicrob Agents Chemother
; 63(10)2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31358585
4.
Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosis.
Br J Clin Pharmacol
; 85(10): 2341-2350, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31269277
5.
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations.
J Infect Dis
; 218(6): 991-999, 2018 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29718390
6.
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.
Clin Infect Dis
; 67(1): 34-41, 2018 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29917079
7.
Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods.
J Antimicrob Chemother
; 72(8): 2311-2319, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28520930
8.
Limiting resources in sessile systems: food enhances diversity and growth of suspension feeders despite available space.
Ecology
; 96(3): 819-27, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26236877
9.
Rituximab pharmacokinetic and pharmacokinetic-pharmacodynamic evaluation based on a study in diffuse large B-cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarity.
CPT Pharmacometrics Syst Pharmacol
; 12(2): 154-167, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36330695
10.
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development.
Front Pharmacol
; 14: 1067295, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36998606
11.
Efficient and relevant stepwise covariate model building for pharmacometrics.
CPT Pharmacometrics Syst Pharmacol
; 11(9): 1210-1222, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35851587
12.
Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients With Severe Asthma.
J Clin Pharmacol
; 62(7): 905-917, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34964491
13.
Population repeated time-to-event analysis of exacerbations in asthma patients: A novel approach for predicting asthma exacerbations based on biomarkers, spirometry, and diaries/questionnaires.
CPT Pharmacometrics Syst Pharmacol
; 10(10): 1221-1235, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34346168
14.
Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictions.
Sci Rep
; 10(1): 15537, 2020 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32968142
15.
A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses.
Clin Pharmacol Ther
; 103(4): 674-683, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28653479
16.
Improving treatment outcome assessment in a mouse tuberculosis model.
Sci Rep
; 8(1): 5714, 2018 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29632372
17.
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin.
Clin Pharmacol Ther
; 104(6): 1208-1218, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29700814
Resultados
1 -
17
de 17
1
Próxima >
>>